Prevention of Prostate Cancer with Vitamins - Current Perspectives

  • Garg, Manish (Department of Urology, King George Medical University, Chhatrapati Shahuji Maharaj Medical University) ;
  • Dalela, Divakar (Department of Urology, King George Medical University, Chhatrapati Shahuji Maharaj Medical University) ;
  • Goel, Apul (Department of Urology, King George Medical University, Chhatrapati Shahuji Maharaj Medical University) ;
  • Kumar, Manoj (Department of Urology, King George Medical University, Chhatrapati Shahuji Maharaj Medical University) ;
  • Sankhwar, Satya Narayan (Department of Urology, King George Medical University, Chhatrapati Shahuji Maharaj Medical University)
  • Published : 2014.03.01


Cancer prostate is the most common solid malignancy in males of developed countries. With increasing knowledge of the aetiology, pathogenesis and natural history of the disease, influences of dietary factors on prostate cancer development have become more evident. There is ample evidence in the literature of significance of dietary constituents for prostate cancer including vitamins A, D and E. Different vitamins have been found to effect the growth and proliferation of prostate cancer cells as evident in epidemiological, experimental and clinical studies. Various factors play the major role in determining the relationship between these vitamins and prostate cancer in terms of environmental, pharmacological, or genetic aspects. To explore these aspects, the present article reviews the literature on the present status of vitamin use for prevention and management of prostate cancer.


  1. McNeil C (2011). Vitamin E and prostate cancer, research focus turns to biologic mechanisms. J Natl Cancer Inst, 103, 1731-4.
  2. Lu QY, Hung JC, Heber D, et al (2001). Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev, 10, 749-56.
  3. Mahabir S, Schendel K, Dong YQ, et al (2008). Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer, 123, 1173-80.
  4. Martini LA, Wood RJ (2009). Milk intake and the risk of type 2 diabetes mellitus, hypertension and prostate cancer. Arq Bras Endocrinol Metabol, 53, 688-94.
  5. McCormick DL, Rao KV, Johnson WD, et al (2010). Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate. Cancer Prev Res, 3, 381-92.
  6. Meydani M (1995). Vitamin E. Lancet, 345, 170-5.
  7. Milne DB, Botnen J (1986). Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem, 32, 874-6.
  8. Mondul AM, Watters JL, Mannisto S, et al (2011). Serum Retinol and Risk of Prostate Cancer. Am J Epidemiol, 173, 813-21.
  9. Mongan NP, Gudas LJ (2007). Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation, 75, 853-70.
  10. Neuhouser ML, Barnett MJ, Kristal AR, et al (2009). Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev, 18, 2202-6.
  11. Omenn GS, Goodman GE, Thornquist MD, et al (1996). Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst, 88, 1550-9.
  12. Lee HJ, Ju J, Paul S, et al (2009). Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activatingPPAR-g. Clin Can Res, 15, 4242-9.
  13. Klein EA, Thompson IM Jr, Tangen CM, et al (2011). Vitamin E and the risk of prostate cancer, the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 306, 1549-56.
  14. Knekt P, Aromaa A, Maatela J, et al (1990). Serum vitamin A and subsequent risk of cancer, cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol, 132, 857-70.
  15. Kovalenko PL, Zhang Z, Yu JG, et al (2011). Dietary vitamin d and vitamin d receptor level modulate epithelial cell proliferation and apoptosis in the prostate. Cancer Prev Res (Phila) 4, 1617-25.
  16. Li GX, Lee MJ, Liu AB, et al (2011). Delta-tocopherol is more active than alpha- or gamma -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prev Res (Phila), 4, 404-13.
  17. Li H, Stampfer MJ, Hollis JB, et al (2007). A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med, 4, 562-71.
  18. Lippman SM, Klein EA, Goodman PJ, et al (2009). Effect of seleniumand vitamin E on risk of prostate cancer and other cancers, the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 301, 39-51.
  19. Liu G, Wilding G, Staab MJ, et al (2003). Phase II study of 1ahydroxyvitamin D2 in the treatment of advanced androgen independent prostate cancer. Clin Cancer Res, 9, 4077-83.
  20. Lu G, Xiao H, Li G, et al (2010). $\gamma$-tocopherols-rich mixture of tocopherols inhibits chemically-induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis, 31, 687-94.
  21. Ju J, Picinich SC, Yang Z, et al (2010). Cancer preventive activities of tocopherols and tocotrienols. Carcinogenesis, 31, 533-42.
  22. Huss WJ, Lai L, Barrios RJ, Hirschi KK, Greenberg NM (2004). Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate, 61, 142-52.
  23. Jacobs ET, Giuliano AR, Martinez ME, et al (2004). Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol, 89-90, 533-7.
  24. Jiang AL, Zhang PJ, Chen WW, et al (2006). Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP. Asian J Androl, 8, 435-41.
  25. Karimi G, Shahar S, Homayouni N, et al (2012). Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev, 13, 4249-53.
  26. Karppi J, Kurl S, Laukkanen JA, Kauhanen J (2012). Serum $\beta$-carotene in relation to risk of prostate cancer, the Kuopio Ischaemic Heart Disease Risk Factor study. Nutr Cancer, 64, 361-7.
  27. Key TJ, Allen N, Appleby P, et al (2004). Fruits and vegetables and prostate cancer, no association among 1104 cases in a prospective study of 130 544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer, 109, 119-24.
  28. Key TJ, Appleby PN, Allen NE, et al (2007). Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr, 86, 672-81.
  29. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009). Oxidative stress in prostate cancer. Cancer Lett, 282, 125-36.
  30. Hanchette CL, Schwartz GG (1992). Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer, 70, 2861-9.<2861::AID-CNCR2820701224>3.0.CO;2-G
  31. Giovannucci E, Liu Y, Stampfer MJ, Willett WC (2006). A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 203-10.
  32. Giovannucci E, Pollak M, Liu Y, et al (2003). Nutritional predictors of insulin-like growth factor I and their relationship to cancer in men. Cancer Epidemiol Biomarkers Prev, 12, 84-9.
  33. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC (2003). A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev, 12, 1403-9.
  34. Heinonen OP, Albanes D, Virtamo J, et al (1998). Prostate cancer and supplementation with alpha-tocopherol and beta-carotene, incidence and mortality in a controlled trial. J Natl Cancer Inst, 90, 440-6.
  35. Helzlsouer KJ, Huang HY, Alberg AJ, et al (2000). Association betweenalpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst, 92, 2018-23.
  36. Hsing AW, Comstock GW, Abbey H, Polk BF (1990). Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst, 82, 941-6.
  37. Huang HY, Alberg AJ, Norkus EP, et al (2003). Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol, 157, 335-44.
  38. Huncharek M, Muscat J, Kupelnick B (2008). Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer, A meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer, 60, 421-41.
  39. Fraser DR (2007). Exploration of possible mechanisms linking vitamin D status and dietary calcium to prostate cancer. Br J Nutr, 97, 596-7.
  40. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al (2003). Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer, An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int, 91, 608-12.
  41. Eichholzer M, Stahelin HB, Ludin E, Bernasconi F (1999). Smoking, plasma vitamins D, E, retinol, and carotene, and fatal prostate cancer, seventeen-year follow-up of the prospective Basel study. Prostate, 38, 189-98.<189::AID-PROS3>3.0.CO;2-N
  42. Faupel-Badger JM, Diaw L, Albanes D, et al (2007). Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev, 16, 2784-6.
  43. Gann PH, Ma J, Giovannucci E, et al (1999). Lower prostate cancer risk in men with elevated plasma lycopene levels, results of a prospective analysis. Cancer Res, 59, 1225-30.
  44. Gao X, LaValley MP, Tucker KL (2005). Prospective studies of dairy product and calcium intakes and prostate cancer risk, a meta-analysis. J Natl Cancer Inst, 97, 1768-77.
  45. Gaziano JM, Glynn RJ, Christen WG, et al (2009). Vitamins E and C in the prevention of prostate and total cancer in men, the Physicians'Health Study II randomized controlled trial. JAMA, 301, 52-62.
  46. Gill JK, Franke AA, Steven Morris J, et al (2009). Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk, the Multiethnic Cohort. Cancer Causes Control, 20, 1161-71.
  47. Clagett-Dame M, DeLuca H (2002). The role of vitamin A in mammalian reproduction and embryonic development. Ann Rev Nutr, 22, 347-81.
  48. Cheng TY, Barnett MJ, Kristal AR, et al (2011). Genetic variation in myeloperoxidase modifies the association of serum a-tocopherol with aggressive prostate cancer among current smokers. J Nutr, 141, 1731-7.
  49. Chopra DP, Wilkoff LJ (1979'). Activity of retinoids against benzo(a)pyrene-induced hyperplasia in mouse prostate organ cultures. Eur J Cancer, 15, 1417-23.
  50. Chung M, Balk E, Brendel M, et al (2009). Vitamin D and calcium, systematic review of health outcomes, Evid Rep Technol Assess, 183, 1-420.
  51. Clark LC, Combs GF, Turnbull BW, et al (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-63.
  52. Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF (1998). Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol, 128, 515-23.
  53. Cole BF, Baron JA, Sandler RS, et al (2007). Folic acid for the prevention of colorectal adenomas, a randomized clinical trial. JAMA, 297, 2351-9.
  54. Cook NR, Le IM, Manson JE, Buring JE, Hennekens CH (2000). Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control, 11, 617-26.
  55. Delafontaine P, Song YH, Li Y (2004). Expression, regulation and fuction of IGF-1, IGF1R, and IGF 1 binding proteins in blood vessels. Artherioscler Thromb Vasc Biol, 24, 435-44.
  56. Duester G (2008). Retinoic acid synthesis and signaling during early organogenesis. Cell, 134, 921-31.
  57. Ahn J, Peters U, Albanes D, et al (2008). Serum vitamin D concentration and prostate cancer risk, a nested case-control study. J Natl Cancer Inst, 100, 796-804.
  58. Skinner HG, Schwartz GG (2009). A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev, 18, 575-8.
  59. Skinner HG, Schwartz GG (2009). The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen, a population-based study. Cancer Epidemiol Biomarkers Prev, 18, 2869-73.
  60. Takahashi S, Takeshita K, Seeni A, et al (2009). Suppression of prostate cancer in a transgenic rat model via gammatocopherol activation of caspase signaling. Prostate, 69, 644-51.
  61. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000). Serum vitamin D concentration and prostate cancer risk, a nested case-control study. Cancer Causes Control, 11, 847-52.
  62. Anon (1994). The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study, design, methods, participant characteristics, and compliance. Ann Epidemiol, 4, 1-10.
  63. Barve A, Khor TO, Nair S, et al (2009). Gamma-tocopherolenriched mixedtocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer, 124, 1693-9
  64. Bosetti C, Micelotta S, Dal Maso L, et al (2004). Food groups and risk of prostate cancer in Italy. Int J Cancer, 110, 424-8.
  65. Carruba G (2007). Estrogen and prostate cancer, an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102, 899-911.
  66. Chadha MK, Tian L, Mashtare T, et al (2010). Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer. Cancer, 116, 2132-9.
  67. Rock CL (2007). Multivitamin-multimineral supplements, Who uses them?. Am. J Clin Nutr, 85, 277S-9S.
  68. Peehl DM, Skowronski RJ, Leung GK, et al (1994). Antiproliferative effects of 1,25 dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res, 54, 805-10.
  69. Peterlik M, Cross HS (2009). Vitamin D and calcium insufficiency-related chronic diseases, molecular and cellular pathophysiology. Eur. J Clin Nutr, 63, 1377-86.
  70. Reichman ME, Hayes RB, Ziegler RG, et al (1990). Serum vitamin A and subsequent development of prostate cancer in the first national health and nutrition examination survey epidemiologic follow-up study. Cancer Res, 50, 2311-15.
  71. Rowland GW, Schwartz GG, John ES, Ingles SA (2012). Calcium intake and prostate cancer among African Americans, effect modification by vitamin d receptor calcium absorption genotype. J Bone Miner Res, 27, 187-94.
  72. Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S, Crissman JD (1993). Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate, 22, 147-54.
  73. Schenk JM, Riboli E, Chatterjee N, et al (2009). Serum retinol and prostate cancer risk, A nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev, 18, 1227-31.
  74. Schwartz GG, Hulka BS (1990). Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res, 10, 1307-11.
  75. Schwartz GG (2009).Is serum calcium a biomarker of fatal prostate cancer? Future Oncol, 5, 577-80.
  76. Skinner HG, Schwartz GG (2008). Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev, 17, 2302-5.
  77. WCRF/AICR (1997). Food, Nutrition And The Prevention Of Cancer, A Global Perspective. World Cancer Research Fund / American Institute for Cancer Research.
  78. Weinstein SJ, Peters U, Ahn J, et al (2012). Serum a-tocopherol and c-tocopherol concentrations and prostate cancer risk in the plco screening trial, a nested case-control study. PLoS One, 7, 40204.
  79. Willis MS, Wians FH (2003). The role of nutrition in preventing prostate cancer, a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta, 330, 57-83.
  80. Wiygul JB, Evans BR, Peterson BL, et al (2005). Supplement use among men with prostate cancer. Urology, 6, 161-6.
  81. World Cancer Research Fund/American Institute for Cancer Research.(2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer, A Global Perspective. Washington, DC, American Institute for Cancer Research.
  82. Yang L, Pascal M, Wu X-H (2013). Review of selenium and prostate cancer prevention. Asian Pac J Cancer Prev, 14, 2181-4.
  83. Zheng X, Cui XX, Khor TO, et al (2012). Inhibitory effect of a $\gamma$- tocopherol-rich mixture of tocopherols on the formation and growth of LNCaP prostate tumors in immunodefficient mice. Cancers, 3, 3762-72.
  84. Ozten N, Horton L, Lasano S, Bosland MC (2010). Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradioltreated NBL rat model. Cancer Prev Res, 3, 371-80.
  85. Park S-Y, Murphy SP, Wilkens LR, et al (2007). Calcium, vitamin D and dairy product intake and prostate cancer risk. The multiethnic cohort study. Am J Epidemiol, 166, 1259-69.
  86. Peehl DM, Feldman D (2003). The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer, 10, 131-40.
  87. Tseng M, Giri V, Bruner DW, Giovannucci E (2009). Dairy intake and 1,25-dihydroxyvitamin d levels in men at high risk for prostate cancer. Cancer Causes Control, 20, 1947-54.
  88. Velicer CM, Ulrich CM (2008). Vitamin and mineral supplement use among US adults after cancer diagnosis, A systematic review. J Clin Oncol, 26, 665-673.
  89. Travis RC, Crowe FL, Allen NE, et al (2009). Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Epidemiol, 169, 1223-32.
  90. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005). Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr, 81, 1147-54.
  91. Weaver CM (2009). Should dairy be recommended as part of a healthy vegetarian diet? Point. Am J Clin Nutr, 89, 1634-7.

Cited by

  1. Fruit and Vegetable Intake in Relation to Prostate Cancer in Iranian Men: A Case-Control Study vol.15, pp.13, 2014,
  2. Conditional PTEN-deficient Mice as a Prostate Cancer Chemoprevention Model vol.16, pp.5, 2015,
  3. Biomarkers for Evaluation of Prostate Cancer Prognosis vol.16, pp.7, 2015,
  4. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway vol.37, pp.1, 2016,